2019
DOI: 10.1177/2192568219833336
|View full text |Cite
|
Sign up to set email alerts
|

Allogenic Stem Cells in Spinal Fusion: A Systematic Review

Abstract: Study Design: Systematic review. Objectives: To review, critically appraise, and synthesize evidence on the use of allogenic stem cell products for spine fusion compared with other bone graft materials. Methods: Systematic searches of PubMed/MEDLINE, through October 31, 2018 and of EMBASE and ClinicalTrials.gov through April 13, 2018 were conducted for literature comparing allogenic stem cell sources for fusion in the lumbar or cervical spine with other fusion methods. In the absence of comparative studies, ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
18
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(18 citation statements)
references
References 50 publications
0
18
0
Order By: Relevance
“…24 However, the current evidence regarding the efficacy and safety of cellular allografts for cervical arthrodesis is limited, with no published studies comparing cellular allograft with other grafting materials. 25 In this research, we aimed to explore the utility of cellular allograft in the promotion of successful arthrodesis and postoperative clinical outcomes, comparing patients who underwent multilevel ACDF augmented with cellular allograft with patients who underwent ACDF supplemented with decellularized allograft. The primary outcome was construct fusion at the 1-year follow-up as observed on CT.…”
mentioning
confidence: 99%
“…24 However, the current evidence regarding the efficacy and safety of cellular allografts for cervical arthrodesis is limited, with no published studies comparing cellular allograft with other grafting materials. 25 In this research, we aimed to explore the utility of cellular allograft in the promotion of successful arthrodesis and postoperative clinical outcomes, comparing patients who underwent multilevel ACDF augmented with cellular allograft with patients who underwent ACDF supplemented with decellularized allograft. The primary outcome was construct fusion at the 1-year follow-up as observed on CT.…”
mentioning
confidence: 99%
“…The use of cellular based allografts is an alternate treatment option which has reported promising results in foot and ankle arthrodesis. However, evidence remains limited for these regenerative therapies involving multipotent adult progenitor cells [ 3 , 17 ]. Demineralized bone matrices (DBMs) and the allografts present osteo-conductive and osteo-inductive properties.…”
Section: Discussionmentioning
confidence: 99%
“…We compared cancellous bone versus various DBMs versus various ACBMs in terms of product cost per cubic centimeter. On average (across various manufacturers), cancellous bone products cost $17 per cm 3 , DBM products cost $151 per cm 3 , and ACBM products cost $525 per cm 3 (Table 4). Thus, ACBMs are being sold at a premium in comparison to other bone graft substitutes.…”
Section: Acbms: the Economic Perspectivementioning
confidence: 99%
“…1,2 The inability to achieve solid arthrodesis after performing spinal fusion frequently results in poor clinical outcomes, instrumentation failures, increased rates of revision surgery, and escalation of treatment costs. 3 In addition to rigid spinal fixation with instrumentation, an essential component for solid arthrodesis is the bridging of bone surfaces, either with collected autograft or with commercial allograft products. The ideal graft material for spinal fusion must possess three critical physiological properties for achieving solid arthrodesis: osteogenesis, osteoinduction, and osteoconduction.…”
mentioning
confidence: 99%